All Pathways
Critical CareManagement

ICU Pain Assessment and Management

ICU Pain Assessment and Management: ICU Patient - Pain Assessment → Patient Can Self-Report Pain? → Use Numeric Rating Scale (NRS) → Significant Pain Pr...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    ICU Patient - Pain Assessment

    Routine pain assessment for all ICU patients

    1. Decision

      Patient Can Self-Report Pain?

      Self-report is gold standard

      1. Action

        Use Numeric Rating Scale (NRS)

        0-10 scale for verbal patients

        • 0 = No pain
        • 1-3 = Mild pain
        • 4-6 = Moderate pain
        • 7-10 = Severe pain
        • Target: NRS ≤3
        1. Decision

          Significant Pain Present?

          NRS ≥4 or CPOT ≥3 or BPS ≥5

          1. Action

            Continue Monitoring

            Reassess regularly

            • Routine assessment q4h
            • Before/after procedures
            • Anticipate pain with procedures
            • Preemptive analgesia for procedures
            1. Outcome

              Pain Controlled

              NRS ≤3, CPOT <3, patient comfortable

          2. Action

            Analgesia-First Approach

            Treat pain before sedation

            • Pain is primary driver of agitation
            • Treat pain → may reduce sedation needs
            • PADIS: Analgesia-first, analgesia-based sedation
            1. Action

              Select Opioid Analgesic

              IV opioids first-line for ICU pain

              • Fentanyl: 25-100 mcg IV q1-2h PRN
              • - Preferred: hemodynamic instability, renal failure
              • - Continuous: 25-200 mcg/hr
              • Hydromorphone: 0.2-0.6 mg IV q2-3h
              • - Less histamine release than morphine
              • Morphine: 2-4 mg IV q2-4h
              • - Caution: renal failure (M6G accumulation)
              1. Action

                Consider Multimodal Analgesia

                Opioid-sparing strategies

                • Acetaminophen: 650-1000mg q6h (IV or PO)
                • - Max 3-4g/day, caution hepatic disease
                • NSAIDs: Short-term only if no CI
                • - Caution: AKI, bleeding, cardiac
                • Ketamine: Low-dose 0.1-0.5 mg/kg/hr
                • - Adjunct for refractory pain
                • Gabapentin/Pregabalin: neuropathic pain
                1. Action

                  Reassess Pain Response

                  15-30 min after intervention

                  • Reassess using same scale
                  • Titrate to target (NRS ≤3, CPOT <3)
                  • Document response
                  • Adjust regimen as needed
                  1. Outcome

                    Pain Refractory

                    Consider pain consult, regional techniques

              2. Action

                Procedural Pain Management

                Anticipate and prevent procedure pain

                • Pre-procedure bolus (fentanyl 50-100 mcg)
                • Increase sedation temporarily
                • Local anesthesia when possible
                • Non-pharm: positioning, distraction
      2. Action

        Use Behavioral Pain Scale

        For patients who cannot self-report

        • CPOT (Critical-Care Pain Observation Tool)
        • BPS (Behavioral Pain Scale)
        • CPOT ≥3 or BPS ≥5 = significant pain
        • Assess q4h and PRN
        • Before/after painful procedures

Guideline Source

Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Pain assessment challenging in sedated/intubated patients
  • Behavioral pain scales require training
  • Opioid dosing varies with renal/hepatic function
  • Does not address chronic pain management
  • Multimodal analgesia availability varies

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

Global: PADIS guidelines widely adopted

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the ICU Pain Assessment and Management?

The ICU Pain Assessment and Management is a management clinical algorithm for Critical Care. It provides a structured decision tree to guide clinical decision-making, based on Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

What guideline is the ICU Pain Assessment and Management based on?

This algorithm is based on Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (DOI: 10.1097/CCM.0000000000002375).

What are the limitations of the ICU Pain Assessment and Management?

Known limitations include: Pain assessment challenging in sedated/intubated patients; Behavioral pain scales require training; Opioid dosing varies with renal/hepatic function; Does not address chronic pain management; Multimodal analgesia availability varies. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the ICU Pain Assessment and Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free